While logistical challenges have hampered use of antibody drugs to treat people with mild-to-moderate COVID-19, recent results show the medicines can be worthwhile.
(Image credit: Craig F. Walker/Boston Globe via Getty Images)
Subscribe to:
Post Comments
(
Atom
)
Post a Comment